U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07446894) titled 'Phase III Trial of MSA-01 in Multiple System Atrophy' on Feb. 25.
Brief Summary: The purpose of this study is to evaluate whether MSA-01 slows the progression of multiple system atrophy (MSA) and to assess its safety.
The primary question is:
* Does MSA-01 slow the progression of motor impairment as measured by UMSARS Part 2 score?
Participants will be randomly assigned to receive MSA-01 or placebo for 12 months. They will attend regular clinic visits for safety and efficacy assessments and record their medication use and any side effects in a diary.
Study Start Date: Feb. 09
Study Type: INTERVENTIONAL
Condition:
Multiple Sys...